Amylyx Pharmaceuticals Inc (AMLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 77,391 | 170,201 | 62,526 | 50,191 | 12,877 |
| Marketable Securities | 99,110 | 201,161 | 284,419 | 45,927 | N/A |
| Receivables | 447 | 40,050 | 15,306 | N/A | N/A |
| Inventories | N/A | 38,323 | 9,769 | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 3,441 | 0 |
| TOTAL | $189,432 | $464,666 | $382,133 | $104,951 | $13,639 |
| Non-Current Assets | |||||
| PPE Net | 961 | 2,686 | 2,611 | 474 | 151 |
| Other Non-Current Assets | 3,241 | 50,102 | 6,709 | 189 | 314 |
| TOTAL | $4,202 | $52,788 | $9,320 | $663 | $465 |
| Total Assets | $193,634 | $517,454 | $391,453 | $105,614 | $14,104 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,939 | 22,061 | 6,257 | 4,372 | 3,613 |
| Accrued Expenses | 23,949 | 57,724 | 38,312 | 13,024 | 3,713 |
| TOTAL | $28,406 | $82,042 | $46,609 | $17,396 | $7,326 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 1,425 |
| Other Non-Current Liabilities | 463 | 1,980 | 4,237 | 0 | 2 |
| TOTAL | $463 | $1,980 | $4,237 | $35 | $1,441 |
| Total Liabilities | $28,869 | $84,022 | $50,846 | $17,431 | $8,767 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 88,602 | 67,782 | 66,716 | N/A | N/A |
| Common Shares | 7 | 7 | 7 | 1 | 1 |
| Retained earnings | -606,692 | -304,949 | -354,220 | -155,845 | -67,914 |
| Other shareholders' equity | -92 | 197 | -86 | 239,360 | 72,062 |
| TOTAL | $164,765 | $433,432 | $340,607 | $88,183 | $5,337 |
| Total Liabilities And Equity | $193,634 | $517,454 | $391,453 | $105,614 | $14,104 |